Pharmion
Acquired
- Headquarters
- Boulder, Colorado
- Employees
- 201–500
- Founded
- 1999
- Business Model
- B2B
- Website
- pharmion.com
- Total Funding
- $105.0M
- Last Round
- $40.0M Series BNov 2002
About
Pharmion Corporation was a specialty pharmaceutical company headquartered in Boulder, Colorado, focused on acquiring and commercializing innovative medicines for hematology and oncology, particularly for European and other international markets. Founded in 1999, Pharmion commercialized drugs including azacitidine (Vidaza) and thalidomide for hematologic malignancies, and was acquired by Celgene Corporation in 2008.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account